Strata Critical Medical, Inc. SRTA
Nasdaq · XNAS · stock · Services-Health Services · website · IPO 2019-09-17
Strata Critical Medical, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 20.9% | 20.2% | — | — | — |
| Operating margin | -11.3% | -15.3% | -30.3% | -36.6% | -47.7% |
| Net margin | 21.0% | -18.6% | -24.9% | -18.7% | -79.3% |
| FCF margin | -29.7% | -22.7% | -15.3% | -25.9% | -31.5% |
| Return on assets | 12.7% | -10.6% | -19.0% | -8.4% | -11.7% |
| Return on equity | 14.8% | -12.3% | -23.9% | -9.9% | -13.8% |
| Debt / equity | — | — | — | 0.00× | — |
| Current ratio | 6.38 | 7.07 | 5.81 | 8.20 | 32.99 |
| Revenue growth | 34.3% | -34.8% | 54.1% | 189.2% | — |
Source: SEC EDGAR filings · CIK 0001779128 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.